Scent Safety for Stunt-Heavy Productions: Lessons from Carrie Coon’s Broadway Allergic Reaction
industrytheatresafety

Scent Safety for Stunt-Heavy Productions: Lessons from Carrie Coon’s Broadway Allergic Reaction

bbestperfumes
2026-08-31
9 min read

A practical industry guide—lessons from Carrie Coon’s allergic reaction for safer fake blood use, scent-free backstage policies and allergy protocols.

When a single scent can stop a run: why productions must treat fragrance and prop chemistry as safety issues

Last-minute cancellations, bewildered stage managers and a shaken lead actor: Carrie Coon’s onstage allergic reaction to the fake blood used in the Broadway production of Bug is the most visible reminder yet that stage safety now includes scent and chemical risk management. If your production still treats perfumes, prop fluids and adhesive choices as “minor” creative details, this incident should change that mindset.

Key takeaways up front

  • Immediate risk: Sprayed or aerosolised stage fluids and fragranced products can provoke allergic or respiratory reactions, forcing cancellations and exposing productions to liability.
  • Preventable: Most incidents are avoidable with proper vendor vetting, ingredient transparency, patch testing and clear perfume policies.
  • Practical action: Implement a scent-free backstage policy, require MSDS (Material Safety Data Sheets) for all prop fluids, and adopt a rehearsed allergy protocol.

What happened: the Carrie Coon incident in context

In January 2026, actress Carrie Coon disclosed that a mysterious string of cancellations during previews for the Broadway revival of Bug stemmed from “some sort of onstage allergic reaction” to the fake blood used in the production. The reaction reportedly began during a scene in which stage blood was sprayed to simulate a nosebleed, a method that directly exposes mucous membranes to the prop fluid. That sequence of events — application method, lack of transparent ingredient briefing, and immediate health impact — is a textbook case of how theatrical realism can collide with cast health.

"She had some sort of onstage allergic reaction to the fake stage blood used throughout the more violent scenes of the play."
— Reported in Deadline, January 2026

Several developments in late 2025 and early 2026 have made scent and prop chemical safety a boardroom issue for theatres and film sets:

  • Greater public awareness of multiple chemical sensitivity (MCS) and fragrance-triggered asthma has increased pressure on employers to provide safe working environments.
  • Unions and insurers are pushing productions to document health and safety measures more rigorously, especially after high-profile cancellations and claims.
  • New, eco-friendly prop formulations have entered the market — but “green” doesn’t always mean non-reactive; ingredient transparency remains inconsistent.
  • Technologies such as wearable VOC sensors and real-time air-monitoring systems are becoming affordable and practical for larger productions.

Immediate checklist for productions (start tonight)

  • Stop any practice that sprays prop fluids directly into actors’ faces or noses until risk assessment and patch testing are completed.
  • Collect MSDS and full ingredient lists for every prop fluid, adhesive and makeup product used onstage; store them in a central, accessible folder.
  • Issue a temporary scent-free backstage advisory—notify cast, crew and visiting personnel in writing and with signage.
  • Designate an on-call first-aid lead and ensure antihistamines, epinephrine (if prescribed), oxygen and an emergency plan are in place.

Fake blood safety: supplier vetting, formulations and application

Fake blood is an artistic staple, but the way it’s formulated and applied determines safety. The Carrie Coon case underscores three failure points: unknown ingredients, an application method that aerosolised the fluid, and inadequate rehearsal of medical contingencies.

Supplier and product selection

  • Require full ingredient disclosure and a current MSDS before you buy. If a supplier will not provide these, do not use their product.
  • Prefer water-based, dye-stable formulas with a minimal preservative system. Avoid products with strong fragrances, unknown solvents or volatile organic compounds (VOCs).
  • Request allergen declarations (e.g., latex, shellfish derivatives, soy, nut oils) from suppliers. Many speciality brands will produce allergen-free versions on request.

Application protocols

  • Avoid spraying directly into the face or nasal passages. Use controlled applicators (swabs, pumps with short nozzles, prosthetic reservoirs) and never exceed a pre-agreed volume per take.
  • Consider prosthetic alternatives: sealed nasal prosthetics with internal staining, blood packs that release fluid externally, or lighting/camera tricks to imply blood without contact.
  • For stunts: rehearse with the same product and application method under full performance conditions, and document all rehearsals with a signed consent from actors.
  • Use nitrile gloves and eye protection during preparation; keep a clean area for mixing and single-use applicators.

Patch testing and medical sign-off

  • Perform a 48–72 hour patch test on all performers who will be exposed to the product. Document results.
  • For anything approaching mucous membrane exposure, require medical sign-off from a production physician or an independent clinician.

Designing a practical perfume policy for theatre and film

Perfume policies are now a standard part of backstage risk management. A policy must be enforceable, inclusive and backed by leadership. Below is a concise, ready-to-adopt blueprint.

Sample perfume policy (template)

Purpose: To protect the health of cast, crew and audience members by minimising exposures to fragranced products that may cause allergic or respiratory reactions.

Scope: Applies to all employees, contractors, freelancers, visitors and vendors while on premises or during site-based rehearsals, filming or performances.

  1. Fragrance-free expectation: Please avoid wearing perfumes, colognes, scented lotions, strongly-scented hair products and heavily fragranced laundry detergents when reporting for work or performance.
  2. Enforcement: Stage management and department heads may remind individuals who are in breach. Repeat breaches may lead to removal from the premises.
  3. Supplies: Unscented soaps, detergents and hand creams will be provided in backstage and green-room areas.
  4. Exemptions: Medical exemptions (e.g., smell training prescribed by an otolaryngologist) will be accommodated; the individual must notify production in advance and propose mitigation steps.
  5. Communication: Notices will be posted at callboards, included in contracts and reiterated at company meetings.

Practical enforcement tips

  • Supply fragrance-free amenities and launderers for costume departments to standardise scent levels.
  • Train department heads to give respectful reminders; frame the policy as a health accommodation, not a personal critique.
  • Include the policy in cast contracts and audition notices so guests are aware in advance.

Allergy protocol and emergency response: roles and steps

Every production must have a rehearsed allergy response integrated into its existing emergency plan. The following protocol is minimal and should be adapted to local law and union requirements.

Onstage allergic reaction: immediate steps

  1. Stop the action and move the affected performer to a safe, well-ventilated area.
  2. Remove the suspected irritant (wash face/skin with water, remove prosthetics, air out the area).
  3. Administer prescribed medications (antihistamine or epinephrine auto-injector) if available and trained personnel present.
  4. Call emergency services if there are signs of respiratory distress, swelling of the throat, dizziness or loss of consciousness.
  5. Document the incident with time-stamped notes, witness statements and photos if relevant; keep the product sample for testing.

Post-incident actions

  • Conduct a formal risk assessment; halt further use of the product until lab analysis and medical review confirm safety.
  • Notify insurer and unions as appropriate; follow mandatory reporting requirements.
  • Review and update policies: supplier approval, patch-testing requirements and rehearsal processes.

Choosing non-reactive stage materials for stunts and prosthetics

Beyond prop fluids, adhesives, prosthetic materials and fabrics can provoke contact dermatitis and respiratory symptoms. Consider these guiding principles:

  • Ingredient transparency: Treat adhesives, silicones, latex alternatives and pigments like controlled substances. Require supplier declarations and MSDS.
  • Latex awareness: Latex allergy remains common. Where possible, specify latex-free prosthetics and test adhesives on the actor before full application.
  • Adhesive removers: Use hypoallergenic removers and ensure clean removal protocols to reduce skin trauma and sensitisation.
  • Costume laundering: Use fragrance-free detergents and avoid fabric softeners. Consider pre-washing new costumes and provide multiple sets to avoid re-exposure between performances.

Industry practice: union, insurer and venue considerations

While this guide does not replace legal advice, three practical steps will strengthen your position with unions and insurers:

  • Document your risk assessments and communication with crews—auditable records reduce claim exposure.
  • Engage occupational health professionals early for high-risk productions (intense gore, aerosolised fluids, repeated prosthetic work).
  • Update contracts and rider clauses to include explicit consent and medical disclosure requirements when stunts involve bodily fluids or direct mucous membrane contact.

Technology and the future of scent safety (2026 and beyond)

Two technology trends are likely to change how productions manage scent risk in 2026:

  • Real-time air monitoring: Portable VOC and particulate sensors are increasingly affordable. Productions can deploy short-term monitors during rehearsals to detect unexpected spikes from prop use.
  • Digital policy platforms: Apps that distribute safety policies, record consent, and collect medical alerts are helping teams maintain compliance and create searchable incident logs.

Additionally, manufacturers are investing in hypoallergenic prop materials that avoid common preservatives and fragrances while maintaining theatrical effect. But procurement still requires due diligence: a “hypoallergenic” label is not a substitute for ingredient data.

Actionable checklist: what to implement this month

  1. Mandate MSDS and ingredient lists for all prop fluids, adhesives and makeup used on stage.
  2. Create and publish a scent-free backstage policy; provide unscented supplies.
  3. Introduce a mandatory 48–72 hour patch test for performers exposed to stage blood or prosthetic adhesives.
  4. Stop any practice that sprays fluids into the face or nose until medical sign-off is obtained.
  5. Train first-aid leads on allergic reactions and keep emergency medication accessible.
  6. Record and store all incident reports and supplier communications in a single, auditable file.

Conclusion: protecting creative intent and cast health

Artistic realism should not come at the expense of cast and crew health. Carrie Coon’s allergic reaction is a high-profile reminder: the ingredients, application methods and backstage culture around scents and prop fluids matter. Productions that treat stage safety as a dynamic, cross-departmental responsibility — combining medical oversight, supplier transparency and clear fragrance policies — will protect audiences, preserve opening nights and reduce legal and insurance risk.

Final actionable advice

  • Prioritise transparency: demand MSDS and ingredient lists.
  • Substitute high-risk methods (face-spraying) with controlled prosthetics or visual effects.
  • Make scent-free the default backstage culture and back it with clear enforcement.

If your production is preparing for a stunt-heavy run or a show with regular use of stage blood, start with the checklist above and convene a cross-departmental safety meeting this week. The cost of a small change — a different applicator, an alternate formula, a patch test — is far lower than cancelling performances or, worse, injuring a colleague.

Call to action

Download our free backstage scent-free policy template and fake-blood supplier checklist at bestperfumes.co.uk/resources (available immediately), and contact our editorial team for a tailored safety audit. Protect your cast, protect your run — implement a comprehensive scent and chemical safety plan today.

Related Topics

#industry#theatre#safety
b

bestperfumes

Contributor

Senior editor and content strategist. Writing about technology, design, and the future of digital media. Follow along for deep dives into the industry's moving parts.